Imagin Medical Inc. IMEXF

Set alert

Price alert · IMEXF

All alert types
0.00 USD 0.00 0.00%

At close · Oct 30

0.01 Day range 0.011
0.0001 52-week range 0.011
YTD
0.00%
1 year
0.00%
Open
0.011
Prev close
0.0001
Mkt cap
1.08K
Vol
30.54K
Avg vol
0
EPS
-0.26
P/E
0.00
More statistics
Low
0.01
High
0.011

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for IMEXF has not been loaded yet. Try again in a moment.

Discussion (3)

Sign in to join the discussion

cardinal14 IMEXF 6 years ago #1

Join us on October 29, 2020 at 12:00 pm ET
Click here to register
Imagin Medical is a surgical imaging company focused on advancing new methods of visualizing cancer during minimally invasive procedures. The Company believes its first product, the i/Blue™ Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting cancer for removal, helping to reduce recurrence rates. The Company’s initial focus is bladder cancer, the sixth most prevalent cancer in North America and the third most prevalent cancer among men, with a recurrence rate of more than 50%.

Keynote speaker
Jim Hutchens, President and CEO of Imagin Medical

Participants
Ashish M. Kamat, MD - M.D. Anderson Cancer Center, Houston
Alexandre Zlotta, MD - Director of Uro-Oncology, Mt Sinai Hospital, Toronto
Mehrdad Alemozaffar, MD - Kaiser Permanente, Los Angeles
Ron Insana - Senior Analyst, CNBC and Financial Industry Expert

cardinal14 IMEXF 6 years ago #2

Join us on October 29, 2020 at 12:00 pm ET
Click here to register
Imagin Medical is a surgical imaging company focused on advancing new methods of visualizing cancer during minimally invasive procedures. The Company believes its first product, the i/Blue™ Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting cancer for removal, helping to reduce recurrence rates. The Company’s initial focus is bladder cancer, the sixth most prevalent cancer in North America and the third most prevalent cancer among men, with a recurrence rate of more than 50%.

Keynote speaker
Jim Hutchens, President and CEO of Imagin Medical

Participants
Ashish M. Kamat, MD - M.D. Anderson Cancer Center, Houston
Alexandre Zlotta, MD - Director of Uro-Oncology, Mt Sinai Hospital, Toronto
Mehrdad Alemozaffar, MD - Kaiser Permanente, Los Angeles
Ron Insana - Senior Analyst, CNBC and Financial Industry Expert

cardinal14 IMEXF 6 years ago #3

This is about to go wayyyyyyy up!!! Completely under the radar but about to come out. Built by and backed by the top device and urologist professionals in the world